Classes and predictors of reversal in male patients with congenital hypogonadotropic hypogonadism: a cross-sectional study of six international referral centres [0.03%]
六家国际转诊中心的成人先天性低促性腺激素性性腺功能减退症患者的逆转分类及预测因素：一项横断面研究
Andrew A Dwyer,Isabella R McDonald,Biagio Cangiano et al.
Andrew A Dwyer et al.
Background: Although some male patients with congenital hypogonadotropic hypogonadism (CHH) undergo spontaneous reversal following treatment, predictors of reversal remain elusive. We aimed to assemble the largest cohort ...
Shahrad Taheri
Shahrad Taheri
5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study [0.03%]
在英国糖尿病逆转临床试验(DiRECT)中对持续减肥支持进行的5年随访：一项扩展研究
Michael Ej Lean,Wilma S Leslie,Alison C Barnes et al.
Michael Ej Lean et al.
Background: In DiRECT, a randomised controlled effectiveness trial, weight management intervention after 2 years resulted in mean weight loss of 7·6 kg, with 36% of participants in remission of type 2 diabetes. Of 36 in ...
Randomized Controlled Trial
The lancet. Diabetes & endocrinology. 2024 Apr;12(4):233-246. DOI:10.1016/S2213-8587(23)00385-6 2024
Eleanor M Scott,Helen R Murphy,Karen Kennedy et al.
Eleanor M Scott et al.
Milestone achievement for global access to blood glucose meters and test strips [0.03%]
血糖仪及检测试纸全球准入里程碑成就
Emma Klatman,Beatrice Vetter,Cathy Haldane et al.
Emma Klatman et al.
Ashley H Ng,Matthew Quigley,Tim Benson et al.
Ashley H Ng et al.
Denosumab in the treatment of osteoporosis associated with chronic kidney disease [0.03%]
狄诺塞麦在慢性肾病相关骨质疏松治疗中的应用
Adrian Covic,Mugurel Apetrii
Adrian Covic
The Lancet Diabetes Endocrinology
The Lancet Diabetes Endocrinology